These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 13139438)
1. [Depot effect of influenza adsorbate vaccine]. HENNEBERG G; WENGEL E Arch Gesamte Virusforsch; 1953; 5(3):237-41. PubMed ID: 13139438 [No Abstract] [Full Text] [Related]
2. [Comparative mouse immunization with 2 influenza A2-adsorbate vaccines]. HERZBERG K; VANEK E Z Hyg Infektionskr; 1960; 147():133-43. PubMed ID: 13713875 [No Abstract] [Full Text] [Related]
3. Effect of dosage and interval between injections on the antibody response to polyvalent influenza vaccine. MOGABGAB WJ; HOLMES B; BRIGHTWELL RJ; RESLER CW J Lab Clin Med; 1961 Sep; 58():391-404. PubMed ID: 13771680 [No Abstract] [Full Text] [Related]
4. Influenza vaccine. SMADEL JE Public Health Rep (1896); 1958 Feb; 73(2):129-32. PubMed ID: 13505997 [No Abstract] [Full Text] [Related]
5. A controlled test of Asian influenza vaccine in a population of families. SELTSER R; SARTWELL PE; BELL JA Am J Hyg; 1962 Jan; 75():112-35. PubMed ID: 13910491 [No Abstract] [Full Text] [Related]
6. [Effect of liver virus concentrations in anti-influenza vaccine on its immunological activity]. DEICHMAN GI; GRIGOR'EVA AG; VENUSTOV NV Vopr Virusol; 1958; 3(6):357-62. PubMed ID: 13636153 [No Abstract] [Full Text] [Related]
7. [Duration of immunity in subjects vaccinated with live anti-influenza vaccine]. GUSTYREV VF Vopr Virusol; 1959; 4(2):157-61. PubMed ID: 13659961 [No Abstract] [Full Text] [Related]
8. [Influenza vaccine cultivation]. GROSS WO Arch Gesamte Virusforsch; 1959; 8(5):632-5. PubMed ID: 13650534 [No Abstract] [Full Text] [Related]
9. Some problems in the standardization and control of influenza vaccine in 1957. MURRAY R Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():160-7. PubMed ID: 13727031 [No Abstract] [Full Text] [Related]
11. [Preparation and use of anti-influenza vaccine]. LACORTE JG; MONTEIRO E; LOURES JC Hospital (Rio J); 1962 Aug; 62():371-8. PubMed ID: 14461422 [No Abstract] [Full Text] [Related]
12. [Immunogenic properties of living anti-influenza vaccine and causes of infection of vaccinated subjects]. ZAKSTEL'SKAIA LIa; IAKHNO MA; EFINOVA VA Vopr Virusol; 1957; 2(4):213-9. PubMed ID: 13530878 [No Abstract] [Full Text] [Related]
13. [A study on living influenza vaccine]. OKUNO Y Sogo Igaku; 1962 Mar; 19():247-8. PubMed ID: 14481661 [No Abstract] [Full Text] [Related]
14. Protection and infection rates in influenza and adenovirus vaccine evaluations. STILLE WT Am J Hyg; 1960 Mar; 71():129-33. PubMed ID: 13834680 [No Abstract] [Full Text] [Related]
15. [The effect of influenza vaccine on the immune system in elderly persons]. Trzonkowski P Pol Merkur Lekarski; 2001 Feb; 10(56):75-9. PubMed ID: 11320581 [TBL] [Abstract][Full Text] [Related]
16. Immunological evaluation of monovalent influenza vaccine in adults and in children. BRUYN HB; LENNETTE EH AMA Arch Intern Med; 1959 Jun; 103(6):914-23. PubMed ID: 13648994 [No Abstract] [Full Text] [Related]
17. Current knowledge of influenza vaccine. DAVENPORT FM JAMA; 1962 Oct; 182():11-3. PubMed ID: 13883724 [No Abstract] [Full Text] [Related]
18. [Bacterial adjuvants in influenza vaccine. II. Use of Salmonella typhosa]. LACORTE JG; MONTEIRO E; LOURES JC Rev Bras Med; 1954 Aug; 11(8):540-2. PubMed ID: 13224922 [No Abstract] [Full Text] [Related]
19. Respiratory disease: a reemphasis of influenza vaccine proihylaxis. BERRY JW Mo Med; 1962 Sep; 59():853-9. PubMed ID: 13868333 [No Abstract] [Full Text] [Related]